Modified FDA Drug Blocks Pediatric Brain Tumor Relapse

Summary: A precision pediatric oncology study unmasked a dual-targeting therapeutic strategy to stop the relapse of medulloblastoma, the most common malignant childhood brain tumor. While initial treatment survival rates are…